Dr. Michal Shoshan

Michal Shoshan graduated in chemistry and biology at Tel-Aviv University (Israel) in 2008 and conducted her Ph.D. studies under the supervision of Prof. Edit Tshuva at the Hebrew University of Jerusalem (Israel), working on the design of peptidic models for copper metallochaperones, both for mechanistic investigation and as drug candidates for Wilson’s disease.

After graduating in 2015, she spent three years at ETH Zurich, where she worked as a Marie Curie postdoctoral fellow in the group of Prof. Helma Wennemers on the development of peptide-coated platinum nanoparticles as antitumor agents.

At the beginning of 2019, Michal started her own research group at the department of chemistry of the University of Zurich, where she works on the development of new candidates for chelation therapy and environmental remediation.


Academic Career

Starting from 2019

Group leader, Department of Chemistry,
University of Zurich

2016 – 2018

Postdoctoral fellow, ETH Zurich
Advisor: Prof. Helma Wennemers

2009 – 2015

Ph.D. in bioinorganic chemistry (direct track),
Hebrew University of Jerusalem

Supervisor: Prof. Edit Y. Tshuva

Thesis title: "Mimetic Peptides of Copper Metallochaperones: Structural Characterization and Potential Treatment for Copper Homeostasis Disorders"

2005 – 2008

B.Sc. in chemistry and biology, Tel-Aviv University

Selected Fellowships and Awards


Nominated by the SCS to represent Switzerland at the 6th EFMC-YMCS meeting


Swiss National Science Foundation Ambizione Research Grant


Larry and Barbara Field and Family Women in Science Fellowship Fund


Marie Curie Intra European Fellowship (IEF)


The Hebrew University fellowship for excellent women postdoctoral fellows


Traveling grant from the authority for research students at The Hebrew University of Jerusalem


Excellence in Teaching Award (consecutive four years) from the Hebrew University, Faculty of Science


Cazali Institute scholarship, Hebrew University of Jerusalem